New partnership connects researchers with global RWE/HEOR suppliers

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/everythingpossible)
(Image: Getty/everythingpossible)
The Scientist.com and HealthEconomics.com partnership connects real-world evidence (RWE) and health economic outcomes research (HEOR) sponsors and providers to help democratize pharmaceutical research, says company exec.

The online marketplace for outsourced research Scientist.com​ has partnered with HealthEconomics.com, which connects HEOR, RWE, and pharma market access to various stakeholder communities.

“This partnership is contributing to the rapid democratization of pharmaceutical research,”​ said Brian Bonnell, vice president of strategic partnerships, Scientist.com.

“Researchers can now use their laptop computer to access almost all the research services they need to run an entire drug research program, from concept to clinic,”​ he told us.

Drug researchers are increasingly using RWE to evaluate potential treatment benefits and risks, in addition to HEOR to analyze health care treatments from the patient and provider perspective, Bonnell explained.

“But, it is difficult and expensive for researchers to find RWE/HEOR suppliers and access critical data,”​ he added. “This partnership will make it easier for researchers to identify and evaluate the best RWE/HEOR suppliers for their needs, and to purchase the data and services they need to speed up value-based healthcare decisions.”

Bonnell said the new platform will address the many challenges facing RWE/HEOR researchers.

“It will enable them to connect with pre-qualified RWE/HEOR suppliers worldwide, evaluate multiple options and then easily purchase the data and services they need without time-consuming legal and finance review,”​ he added. “Both companies are contributing critical expertise to the project.”

Related news

Show more

Related products

show more

Drug Solubility and the Need for Speed

Drug Solubility and the Need for Speed

Lonza Small Molecules | 28-Mar-2023 | Technical / White Paper

A growing number of new chemical entities are highly insoluble, leading to problems with bioavailability. Drug manufacturers therefore have to find ways...

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

Related suppliers

Follow us

Products

View more

Webinars